Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Optimal auxiliary‐covariate‐based two‐phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials

Identifieur interne : 001D94 ( Main/Exploration ); précédent : 001D93; suivant : 001D95

Optimal auxiliary‐covariate‐based two‐phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials

Auteurs : Peter B. Gilbert [États-Unis] ; Xuesong Yu [États-Unis] ; Andrea Rotnitzky [Argentine, États-Unis]

Source :

RBID : ISTEX:6E8E781B3B546224CA95768C6C749694D6028AFF

Abstract

To address the objective in a clinical trial to estimate the mean or mean difference of an expensive endpoint Y, one approach employs a two‐phase sampling design, wherein inexpensive auxiliary variables W predictive of Y are measured in everyone, Y is measured in a random sample, and the semiparametric efficient estimator is applied. This approach is made efficient by specifying the phase two selection probabilities as optimal functions of the auxiliary variables and measurement costs. While this approach is familiar to survey samplers, it apparently has seldom been used in clinical trials, and several novel results practicable for clinical trials are developed. We perform simulations to identify settings where the optimal approach significantly improves efficiency compared to approaches in current practice. We provide proofs and R code. The optimality results are developed to design an HIV vaccine trial, with objective to compare the mean ‘importance‐weighted’ breadth (Y) of the T‐cell response between randomized vaccine groups. The trial collects an auxiliary response (W) highly predictive of Y and measures Y in the optimal subset. We show that the optimal design‐estimation approach can confer anywhere between absent and large efficiency gain (up to 24 % in the examples) compared to the approach with the same efficient estimator but simple random sampling, where greater variability in the cost‐standardized conditional variance of Y given W yields greater efficiency gains. Accurate estimation of E[Y | W] is important for realizing the efficiency gain, which is aided by an ample phase two sample and by using a robust fitting method. Copyright © 2013 John Wiley & Sons, Ltd.

Url:
DOI: 10.1002/sim.6006


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Optimal auxiliary‐covariate‐based two‐phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials</title>
<author>
<name sortKey="Gilbert, Peter B" sort="Gilbert, Peter B" uniqKey="Gilbert P" first="Peter B." last="Gilbert">Peter B. Gilbert</name>
</author>
<author>
<name sortKey="Yu, Xuesong" sort="Yu, Xuesong" uniqKey="Yu X" first="Xuesong" last="Yu">Xuesong Yu</name>
</author>
<author>
<name sortKey="Rotnitzky, Andrea" sort="Rotnitzky, Andrea" uniqKey="Rotnitzky A" first="Andrea" last="Rotnitzky">Andrea Rotnitzky</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6E8E781B3B546224CA95768C6C749694D6028AFF</idno>
<date when="2014" year="2014">2014</date>
<idno type="doi">10.1002/sim.6006</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-XG36Q0KP-B/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000397</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000397</idno>
<idno type="wicri:Area/Istex/Curation">000397</idno>
<idno type="wicri:Area/Istex/Checkpoint">000178</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000178</idno>
<idno type="wicri:doubleKey">0277-6715:2014:Gilbert P:optimal:auxiliary:covariate</idno>
<idno type="wicri:Area/Main/Merge">001E09</idno>
<idno type="wicri:Area/Main/Curation">001D94</idno>
<idno type="wicri:Area/Main/Exploration">001D94</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Optimal auxiliary‐covariate‐based two‐phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials</title>
<author>
<name sortKey="Gilbert, Peter B" sort="Gilbert, Peter B" uniqKey="Gilbert P" first="Peter B." last="Gilbert">Peter B. Gilbert</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Vaccine Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109</wicri:regionArea>
<wicri:noRegion>WA 98109</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biostatistics, University of Washington, WA 98105, Seattle</wicri:regionArea>
<orgName type="university">Université de Washington</orgName>
<placeName>
<settlement type="city">Seattle</settlement>
<region type="state">Washington (État)</region>
</placeName>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Yu, Xuesong" sort="Yu, Xuesong" uniqKey="Yu X" first="Xuesong" last="Yu">Xuesong Yu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Vaccine Infectious Disease Division, Fred Hutchinson Cancer Research Center, WA 98109, Seattle</wicri:regionArea>
<wicri:noRegion>Seattle</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rotnitzky, Andrea" sort="Rotnitzky, Andrea" uniqKey="Rotnitzky A" first="Andrea" last="Rotnitzky">Andrea Rotnitzky</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Department of Economics, Universidad Di Tella, Buenos Aires</wicri:regionArea>
<wicri:noRegion>Buenos Aires</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Biostatistics, Harvard School of Public Health, MA 02115, Boston</wicri:regionArea>
<placeName>
<settlement type="city">Boston</settlement>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Statistics in Medicine</title>
<title level="j" type="alt">STATISTICS IN MEDICINE</title>
<idno type="ISSN">0277-6715</idno>
<idno type="eISSN">1097-0258</idno>
<imprint>
<biblScope unit="vol">33</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="901">901</biblScope>
<biblScope unit="page" to="917">917</biblScope>
<biblScope unit="page-count">17</biblScope>
<date type="published" when="2014-03-15">2014-03-15</date>
</imprint>
<idno type="ISSN">0277-6715</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0277-6715</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">To address the objective in a clinical trial to estimate the mean or mean difference of an expensive endpoint Y, one approach employs a two‐phase sampling design, wherein inexpensive auxiliary variables W predictive of Y are measured in everyone, Y is measured in a random sample, and the semiparametric efficient estimator is applied. This approach is made efficient by specifying the phase two selection probabilities as optimal functions of the auxiliary variables and measurement costs. While this approach is familiar to survey samplers, it apparently has seldom been used in clinical trials, and several novel results practicable for clinical trials are developed. We perform simulations to identify settings where the optimal approach significantly improves efficiency compared to approaches in current practice. We provide proofs and R code. The optimality results are developed to design an HIV vaccine trial, with objective to compare the mean ‘importance‐weighted’ breadth (Y) of the T‐cell response between randomized vaccine groups. The trial collects an auxiliary response (W) highly predictive of Y and measures Y in the optimal subset. We show that the optimal design‐estimation approach can confer anywhere between absent and large efficiency gain (up to 24 % in the examples) compared to the approach with the same efficient estimator but simple random sampling, where greater variability in the cost‐standardized conditional variance of Y given W yields greater efficiency gains. Accurate estimation of E[Y | W] is important for realizing the efficiency gain, which is aided by an ample phase two sample and by using a robust fitting method. Copyright © 2013 John Wiley & Sons, Ltd.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Argentine</li>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
<li>Washington (État)</li>
</region>
<settlement>
<li>Boston</li>
<li>Seattle</li>
</settlement>
<orgName>
<li>Université de Washington</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Gilbert, Peter B" sort="Gilbert, Peter B" uniqKey="Gilbert P" first="Peter B." last="Gilbert">Peter B. Gilbert</name>
</noRegion>
<name sortKey="Gilbert, Peter B" sort="Gilbert, Peter B" uniqKey="Gilbert P" first="Peter B." last="Gilbert">Peter B. Gilbert</name>
<name sortKey="Rotnitzky, Andrea" sort="Rotnitzky, Andrea" uniqKey="Rotnitzky A" first="Andrea" last="Rotnitzky">Andrea Rotnitzky</name>
<name sortKey="Yu, Xuesong" sort="Yu, Xuesong" uniqKey="Yu X" first="Xuesong" last="Yu">Xuesong Yu</name>
</country>
<country name="Argentine">
<noRegion>
<name sortKey="Rotnitzky, Andrea" sort="Rotnitzky, Andrea" uniqKey="Rotnitzky A" first="Andrea" last="Rotnitzky">Andrea Rotnitzky</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D94 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D94 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6E8E781B3B546224CA95768C6C749694D6028AFF
   |texte=   Optimal auxiliary‐covariate‐based two‐phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021